CVE-2026-47209vm2 is an open source vm/sandbox for Node.js.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
vm2 is an open source vm/sandbox for Node.js. Prior to version 3.11.4, the BaseHandler.set trap in bridge.js (line 1231) ignores the receiver parameter and unconditionally writes to the host target object. Per the Proxy set trap specification, when receiver !== proxy (e.g., when a child object inherits from the proxy via Object.create), the property assignment should create an own property on the receiver, not on the proxy target. The current implementation always calls otherReflectSet(object, key, value) against the host target, causing all inherited property writes to leak through to the host object. This bug provides an alternative attack vector for writing dangerous cross-realm Symbol keys (e.g., nodejs.util.promisify.custom) to host objects, bypassing any future per-trap isDangerousCrossRealmSymbol guard on the direct set path. This issue has been patched in version 3.11.4.
- CVSS
- 8.6 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N
- Weakness (CWE)
- CWE-693
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/patriksimek/vm2/commit/26d0318b5e6555be4b187ba05d6cf378ccecfe22
- https://github.com/patriksimek/vm2/releases/tag/v3.11.4
- https://github.com/patriksimek/vm2/security/advisories/GHSA-c4cf-2hgv-2qv6
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.